About the Authors
- Shaban Ahmad
-
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Software, Validation, Visualization, Writing – original draft, Writing – review & editing
Affiliation Department of Computer Science, Jamia Millia Islamia, New Delhi, India
- Sahar Qazi
-
Roles Formal analysis, Investigation, Writing – review & editing
Affiliation Department of Computer Science, Jamia Millia Islamia, New Delhi, India
- Nagmi Bano
-
Roles Conceptualization, Data curation, Investigation, Software, Visualization, Writing – original draft, Writing – review & editing
Affiliation Department of Computer Science, Jamia Millia Islamia, New Delhi, India
- Rahis Uddin
-
Roles Resources, Validation, Writing – review & editing
Affiliation Department of Chemistry, Jamia Millia Islamia, New Delhi, India
- Pramod Kumar Gautam
-
Roles Supervision, Writing – original draft
Affiliation Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India
- Khalid Raza
-
Roles Funding acquisition, Investigation, Resources, Supervision, Validation, Writing – review & editing
* E-mail: kraza@jmi.ac.in
Affiliation Department of Computer Science, Jamia Millia Islamia, New Delhi, India
Competing Interests
The compound described in this study has been patented under the German patent “Tablettenzusammensetzung mit verlängerter Wirkstofffreisetzung für dieMultitarget-Krebstherapie,” Patent No. [20 2024 101 028.0], and more details are here- https://register.dpma.de/DPMAregister/pat/register?AKZ=2020241010280&CURSOR=8. The present work expands upon the patented concept by presenting detailed results on breast cancer. We confirm that this does not alter our adherence to PLOS ONE policies on sharing data and materials. Furthermore, the existence of the patent does not restrict the availability of materials, methods, or protocols necessary for academic, non-commercial research validation and reproducibility.